INDICATION: BRIUMVI is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. IMPORTANT SAFETY INFORMATION: Contraindication: BRIUMVI is contraindicated in patients with: - Active HBV infection - A history of life-threatening infusion reaction to BRIUMVI
